Hunting for transcription factors: STAT3 decoy in non-small cell lung cancer

類似資料

• Pembrolizumab—the “KEY” to an evolving landscape in treatment of squamous non-small cell lung cancer (NSCLC)
  著者:: Yellala, Amulya, 等
  出版事項: (2020)
• Immunotherapy in treatment naïve advanced non-small cell lung cancer
  著者:: Ernani, Vinicius, 等
  出版事項: (2018)
• Resected small cell lung cancer—what do we do next?
  著者:: Marr, Alissa S., 等
  出版事項: (2016)
• Surgery for limited-stage small cell lung cancer: ready for prime-time?
  著者:: Ernani, Vinicius, 等
  出版事項: (2017)
• EGFR targeted therapy in non-small cell lung cancer: potential role of cetuximab
  著者:: Reade, Chad A, 等
  出版事項: (2009)